Literature DB >> 17345161

Gastric tissue oxidative changes in portal hypertension and cirrhosis.

Yuksel Seckin1, Murat M M Harputluoglu, Kadir Batcioglu, Melih Karincaoglu, Bulent Yildirim, Ramazan I Oner, Burcin Uyumlu, Nurettin Aydogdu, Fatih Hilmioglu.   

Abstract

Gastric mucosal lesions are very common in portal hypertension and cirrhosis. The aim of this study was to assess for oxidative gastric tissue damage in cirrhosis and evaluate relations with portal hypertension and cirrhosis parameters. The study included 30 patients with cirrhosis and 30 controls. Each patient's history, physical examination, and laboratory findings were recorded, and multiple biopsies of the gastric antrum were obtained at endoscopy. A set of antral biopsies was also collected from each control subject. Each tissue specimen was analyzed for levels of glutathione peroxidase (GPX), superoxide dismutase (SOD), and catalase (CAT) activity and level of malondialdehyde (MDA). Patients' gastric GPX, SOD, and CAT levels were significantly lower, and MDA levels were higher, than in the control group. The GPX activity level in the specimens was moderately negatively correlated with portal vein diameter (P<0.05, r=-0.45) and spleen length (P<0.05, r=-0.45). In this study gastric tissue oxidative markers showed that antral oxidative factors worsen in cirrhosis. Oxidative stress may not be a clinical condition but it obviously shows gastric tissue damage and may explain many patients' gastric lesions and hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17345161     DOI: 10.1007/s10620-006-9139-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  14 in total

1.  Glutathione peroxidase activity in selenium-deficient rat liver.

Authors:  R A Lawrence; R F Burk
Journal:  Biochem Biophys Res Commun       Date:  1976-08-23       Impact factor: 3.575

Review 2.  Does portal hypertension contribute to the pathogenesis of gastric ulcer associated with liver cirrhosis?

Authors:  S Kitano; B Dolgor
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

3.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).

Authors:  J M McCord; I Fridovich
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

4.  Determination of malonaldehyde precursor in tissues by thiobarbituric acid test.

Authors:  M Mihara; M Uchiyama
Journal:  Anal Biochem       Date:  1978-05       Impact factor: 3.365

5.  The stomach in liver cirrhosis. Endoscopic, morphological, and clinical correlations.

Authors:  S Vigneri; R Termini; A Piraino; A Scialabba; G Pisciotta; N Fontana
Journal:  Gastroenterology       Date:  1991-08       Impact factor: 22.682

6.  Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC).

Authors:  M Primignani; L Carpinelli; P Preatoni; G Battaglia; A Carta; A Prada; R Cestari; P Angeli; A Gatta; A Rossi; G Spinzi; R De Franchis
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

7.  High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer.

Authors:  S Siringo; D Vaira; M Menegatti; F Piscaglia; S Sofia; M Gaetani; M Miglioli; R Corinaldesi; L Bolondi
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

8.  Helicobacter pylori in cirrhotic patients with peptic ulcer disease: a prospective, case controlled study.

Authors:  C S Wu; C Y Lin; Y F Liaw
Journal:  Gastrointest Endosc       Date:  1995-11       Impact factor: 9.427

9.  Helicobacter pylori infection and peptic ulcer disease in cirrhosis.

Authors:  C J Tsai
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

10.  Portal hypertension and portal hypertensive gastropathy in patients with liver cirrhosis: a haemodynamic study.

Authors:  C Merkel; M Schipilliti; R Bighin; B Bellini; P Angeli; M Bolognesi; F Vescovi; A Gatta
Journal:  Dig Liver Dis       Date:  2003-04       Impact factor: 4.088

View more
  4 in total

1.  Antioxidant properties of glutamine and its role in VEGF-Akt pathways in portal hypertension gastropathy.

Authors:  Camila Marques; Francielli Licks; Ingrid Zattoni; Beatriz Borges; Luiz Eduardo Rizzo de Souza; Claudio Augusto Marroni; Norma Possa Marroni
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

2.  Prevalence of Helicobacter pylori and occurrence of gastroduodenal lesions in patients with liver cirrhosis.

Authors:  Gabriele I Kirchner; Winfried Beil; Joerg S Bleck; Micheal P Manns; Siegfried Wagner
Journal:  Int J Clin Exp Med       Date:  2010-12-25

3.  Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients.

Authors:  Shu-Jie Chen; Liang-Jing Wang; Qin Zhu; Jian-Ting Cai; Tao Chen; Jian-Min Si
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

Review 4.  Changes of Intestinal Functions in Liver Cirrhosis.

Authors:  Hiroshi Fukui; Reiner Wiest
Journal:  Inflamm Intest Dis       Date:  2016-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.